$2.49 Billion is the total value of NEA Management Company, LLC's 46 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 12.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPT | SPROUT SOCIAL INC | $244,244,000 | +69.2% | 9,046,080 | 0.0% | 9.82% | +30.2% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $186,253,000 | +167.0% | 7,959,520 | -33.5% | 7.49% | +105.5% |
| OYST | OYSTER POINT PHARMA INC | $171,122,000 | -17.5% | 5,925,287 | 0.0% | 6.88% | -36.5% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $170,997,000 | +268.0% | 17,082,611 | 0.0% | 6.87% | +183.1% | |
| ALLK | ALLAKOS INC | $162,992,000 | +61.5% | 2,268,188 | 0.0% | 6.55% | +24.3% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $153,644,000 | +73.3% | 2,090,678 | 0.0% | 6.18% | +33.3% | |
| NET | CLOUDFLARE INC | $145,935,000 | +53.1% | 4,059,376 | 0.0% | 5.87% | +17.8% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $145,445,000 | +69.0% | 3,449,845 | 0.0% | 5.85% | +30.0% | |
| IMRA | IMARA INC | $110,994,000 | +72.4% | 4,017,170 | 0.0% | 4.46% | +32.6% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $109,544,000 | +46.5% | 4,912,306 | 0.0% | 4.40% | +12.7% | |
| AKUS | New | AKOUOS INC | $96,716,000 | – | 4,298,488 | +100.0% | 3.89% | – |
| ARDX | Sell | ARDELYX INC | $94,344,000 | +2.9% | 13,633,582 | -15.5% | 3.79% | -20.9% |
| AUPH | AURINIA PHARMACEUTICALS INC | $84,056,000 | +12.0% | 5,172,683 | 0.0% | 3.38% | -13.8% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $81,495,000 | +39.0% | 4,187,801 | 0.0% | 3.28% | +7.0% | |
| CSPR | CASPER SLEEP INC | $55,848,000 | +109.1% | 6,226,040 | 0.0% | 2.24% | +60.8% | |
| TRILLIUM THERAPEUTICS INC | $46,407,000 | +100.2% | 5,736,363 | 0.0% | 1.87% | +54.1% | ||
| TRVI | Buy | TREVI THERAPEUTICS INC | $39,090,000 | +167.5% | 5,940,796 | +33.8% | 1.57% | +105.9% |
| MEIP | MEI PHARMA INC | $35,242,000 | +156.5% | 8,533,072 | 0.0% | 1.42% | +97.4% | |
| GLYC | GLYCOMIMETICS INC | $34,175,000 | +64.9% | 9,089,041 | 0.0% | 1.37% | +26.9% | |
| GRTX | GALERA THERAPEUTICS INC | $31,152,000 | -24.8% | 4,362,986 | 0.0% | 1.25% | -42.2% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $30,561,000 | +39.0% | 6,643,704 | 0.0% | 1.23% | +7.0% | |
| AFMD | AFFIMED NV | $28,274,000 | +192.1% | 6,126,488 | 0.0% | 1.14% | +124.7% | |
| OBSV | OBSEVA SA | $27,015,000 | +144.4% | 4,586,563 | 0.0% | 1.09% | +87.9% | |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $20,933,000 | +78.8% | 2,486,062 | 0.0% | 0.84% | +37.6% | |
| AVEO | Buy | AVEO PHARMACEUTICALS INC | $20,358,000 | +122.8% | 3,952,958 | +56.6% | 0.82% | +71.5% |
| GNCA | GENOCEA BIOSCIENCES INC | $16,619,000 | +33.7% | 7,225,676 | 0.0% | 0.67% | +2.9% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $16,383,000 | +29.2% | 1,713,720 | 0.0% | 0.66% | -0.6% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $15,654,000 | +100.0% | 4,141,308 | 0.0% | 0.63% | +53.8% | |
| BE | BLOOM ENERGY CORP | $14,507,000 | +108.0% | 1,333,333 | 0.0% | 0.58% | +60.2% | |
| XENE | XENON PHARMACEUTICALS INC | $12,441,000 | +10.6% | 992,107 | 0.0% | 0.50% | -15.0% | |
| MRKR | MARKER THERAPEUTICS INC | $10,350,000 | +8.9% | 5,000,000 | 0.0% | 0.42% | -16.1% | |
| LUMO | LUMOS PHARMA INC | $8,685,000 | +94.0% | 526,663 | 0.0% | 0.35% | +49.1% | |
| SYBX | SYNLOGIC INC | $8,586,000 | +18.0% | 4,229,410 | 0.0% | 0.34% | -9.2% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $8,539,000 | +113.1% | 956,255 | 0.0% | 0.34% | +64.1% | |
| CTIC | CTI BIOPHARMA CORP | $8,283,000 | +26.1% | 7,140,450 | 0.0% | 0.33% | -2.9% | |
| SENS | Sell | SENSEONICS HOLDINGS INC | $6,249,000 | -66.7% | 16,023,830 | -46.2% | 0.25% | -74.4% |
| RIGL | RIGEL PHARMACEUTICALS INC | $5,935,000 | +17.3% | 3,243,150 | 0.0% | 0.24% | -9.5% | |
| TRVN | TREVENA INC | $5,718,000 | +164.6% | 3,811,691 | 0.0% | 0.23% | +103.5% | |
| ERYP | ERYTECH PHARMA SAadr | $5,719,000 | +71.3% | 625,000 | 0.0% | 0.23% | +32.2% | |
| VRNA | VERONA PHARMA PLCads | $5,708,000 | +13.6% | 1,219,674 | 0.0% | 0.23% | -12.9% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $4,753,000 | +2.3% | 2,382,286 | 0.0% | 0.19% | -21.4% | |
| MLND | MILLENDO THERAPEUTICS INC | $3,110,000 | -66.7% | 1,766,779 | 0.0% | 0.12% | -74.3% | |
| RGLS | REGULUS THERAPEUTICS INC | $1,399,000 | +47.9% | 2,052,455 | 0.0% | 0.06% | +14.3% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $986,000 | +50.3% | 452,167 | 0.0% | 0.04% | +17.6% | |
| TCON | TRACON PHARMACEUTICALS INC | $680,000 | +15.4% | 346,718 | 0.0% | 0.03% | -12.9% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $342,000 | -36.5% | 1,298,274 | 0.0% | 0.01% | -50.0% | |
| ELGXQ | Exit | ENDOLOGIX INC | $0 | – | -249,022 | -100.0% | -0.01% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -333,333 | -100.0% | -0.17% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -3,315,149 | -100.0% | -0.32% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -4,377,518 | -100.0% | -3.55% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -6,138,797 | -100.0% | -15.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.